Damandeep Kaur | Technological Networks | Best Researcher Award

Published on by Network Science

Dr. Damandeep Kaur | Technological Networks | Best Researcher Award

Institute of Applied Physics 'Nello Carrara' | Italy

Dr. Damandeep Kaur is a dedicated researcher in Materials Science and Engineering, currently serving as a Postdoctoral Fellow at the Institute of Applied Physics, CNR, Florence (since July 2024). She earned her Ph.D. (2017–2022) from Thapar Institute of Engineering & Technology, Patiala, India, where her thesis focused on biobased silica from rice husk and straw for the synthesis of biocompatible glasses. She also holds an M.Sc. in Physics (2011–2013) from Kanya Maha Vidyalaya, Jalandhar, affiliated with Guru Nanak Dev University, where she studied the optical properties of magnesium borate glasses. With over a decade of academic and research experience, she previously served as a Postdoctoral Fellow at the University of Trento, Italy (2022–2024), and as a Teaching Associate at Thapar Institute of Engineering & Technology (2018–2021). Dr. Kaur has actively participated in numerous international conferences, workshops, and schools across Europe and North America, including events organized by the American Ceramics Society and European Ceramics Society. She is an active member of several professional bodies such as the American Ceramics Society, European Ceramics Society (Italy chapter), and the Royal Society of Chemistry, and contributes to the research community as a reviewer for Frontiers in Oncology. Her technical skills are enhanced through specialized training in COMSOL Multiphysics, MATLAB, and IELTS C1 certification, reflecting her strong interdisciplinary expertise in materials science, optics, and applied research.

Profiles: Scopus |  Orcid | Google Scholar

Featured Publications

"Structural, luminescent and in vitro studies of europium-doped soda lime phosphate glasses, Luminescence, Priya, R.; Kaur, D.; Attri, K.; Kaur, S.; Sharda, D.; Choudhury, D.; Pandey, O.P., 2024"

"Production of silica nanoparticles from rice husk and rice straw by fungal-mediated biotransformation using Pleurotus florida, Biomass Conversion and Biorefinery, Kaur, D.; Pandey, O.P.; Reddy, M.S., 2023"

"Effect of Crystalline Ceramic Oxide on the Densification-Crystallization Behavior of Binary Lithium-Di Silicate Glass Compositions, Proceedings of the American Society for Composites - 37th Technical Conference, ASC 2022, Rahman, A.; Kaur, D., 2022"

"In-vitro Reactivity and Antibacterial Activity of Agro-waste Derived Silicate and Phosphate Glasses, Research Square, Kaur, D.; Reddy, M.S.; Pandey, O.P., 2021"

"Agro waste as a source of bioactive glass for targeted drug delivery and bone implantation, Journal of Drug Delivery Science and Technology, Damandeep Kaur, 2021"

Oluwakemi Florence Falana | Technological Networks | Young Researcher Award

Published on by Network Science

Dr. Oluwakemi Florence Falana | Technological Networks | Young Researcher Award

Federal University of Technology Akure | Nigeria

Author Profiles

Scopus

Orcid ID

Early Academic Pursuits

Dr. Oluwakemi Florence Falana began her academic journey at Temidire Nursery and Primary School, Ondo (1990–1995) before proceeding to St. Louis Secondary School, Ondo State (1995–2001). Her passion for science and human health drove her into the field of Food Science and Technology, starting with a National Diploma at Ondo State Polytechnic (2003–2005). She further earned her B.Tech (Hons) degree from the Federal University of Technology, Akure (2006–2010), followed by an MSc at Obafemi Awolowo University, Ile-Ife (2011–2014). Her academic progression culminated in a Ph.D. in Food Science and Technology (Human Nutrition) from FUTA in 2025, demonstrating her consistency, focus, and dedication to specialized research in human nutrition.

Professional Endeavors

Dr. Falana’s professional development has been enriched through academic research, conference participation, and active engagement with national professional bodies. Her membership with the Nigerian Institute of Food Science and Technology (since 2008) and the Nigerian Society of Nutrition (2025) reflects her professional recognition. Her NYSC service and training in reproductive health and HIV/AIDS prevention further highlight her community-oriented professional development.

Contributions and Research Focus

Her research primarily explores the nutritional, functional, and therapeutic potentials of underutilized crops such as breadfruit, cassava, and African yam beans. She has consistently examined how these food resources can be enriched and processed to combat malnutrition, obesity, diabetes, and cholesterol-related conditions. Her doctoral thesis (2025) on poundo-breadfruit enriched with legumes and brans demonstrates an innovative approach to food diversification and functional food development.

Impact and Influence

Through her scholarly contributions, Dr. Falana has provided evidence-based insights into functional foods that can address nutritional deficiencies and lifestyle-related diseases. Her journal publications on proximate, mineral, sensory, and functional evaluations of enriched breadfruit-based meals are valuable references for both industry practitioners and academic researchers. By presenting her works in international conferences, she has contributed to discussions on sustainable food systems and innovative dietary solutions for Africa.

Academic Cites

Her published works in reputable journals such as Food Chemistry Advances and Acta Universitatis Sapientiae, Alimentaria stand as academic milestones. These contributions not only expand the scope of knowledge in food science but also serve as citable references for future research on food functionality, product development, and nutrition interventions.

Legacy and Future Contributions

Dr. Falana’s academic legacy lies in her ability to bridge traditional foods with modern nutritional science, promoting healthier dietary alternatives for African communities. Her research on the valorization of underutilized crops positions her as a contributor to food security, poverty reduction, and sustainable development goals (SDGs). In the future, her work is likely to influence policy formulation, curriculum development, and industrial applications in food processing and nutrition.

Conclusion

Dr. Oluwakemi Florence Falana represents a dynamic scholar whose academic growth, research contributions, and professional engagements highlight her as a promising figure in food science and nutrition. With a strong foundation in both theoretical and applied research, her influence is poised to extend beyond academia into practical solutions that address malnutrition, chronic diseases, and food sustainability challenges. Her trajectory suggests that she will continue to leave a lasting impact on the academic community, industry, and society at large.

Notable Publications

“Quality evaluation and pasting properties of poundo-breadfruit blends enriched with African yam beans (Sphenostylis Stenocarpa Harms), wheat bran and rice bran flours" 

  • Author: Oluwakemi Florence Falana; Sunday Abiodun Malomo; Oluwole Steve Ijarotimi
  • Journal: Food Chemistry Advances
  • Year: 2025

 

Cora Sternberg | Meta analysis | Outstanding Scientist Award

Published on by Network Science

Dr. Cora Sternberg | Meta analysis | Outstanding Scientist Award

Weill Cornell Medicine | United States

Author Profiles

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Dr. Cora Sternberg’s academic journey reflects her commitment to excellence from the outset. She completed her medical training with distinction and pursued advanced fellowships, including a Research Fellowship in Immunology at the National Institutes of Health (1976–1977). Her early academic roles as Teaching Assistant at Stanford and Mount Sinai, followed by Clinical Instructor at Cornell University, laid the foundation for her lifelong dedication to education and clinical research. Her Phi Beta Kappa distinction from the University of Pennsylvania marked the start of a career dedicated to innovation and leadership in oncology.

Professional Endeavors

Over four decades, Dr. Sternberg has held prestigious academic and clinical leadership roles. She was Chief of Medical Oncology at San Camillo-Forlanini Hospital in Rome and served as Professor at La Sapienza University, shaping Italy’s oncology community. Since 2018, she has been Professor of Medicine and Clinical Director of the Englander Institute for Precision Medicine at Weill Cornell Medicine and New York-Presbyterian. She has also served as a global faculty member at Temple University, Tufts University, and European institutions.

Contributions and Research Focus

Dr. Sternberg has pioneered groundbreaking research in prostate cancer, bladder cancer, and renal cell carcinoma. She was instrumental in developing practice-changing therapies such as abiraterone, enzalutamide, and darolutamide, significantly improving survival outcomes for prostate cancer patients. Her work in urothelial cancer led to the establishment of M-VAC chemotherapy and global adoption of immunotherapy protocols. She also contributed to the development of pazopanib and other targeted therapies in renal cell carcinoma. Recently, she has expanded her research focus to artificial intelligence in oncology, spearheading initiatives to integrate AI into therapeutic decision-making.

Impact and Influence

With over 546 publications, six textbooks, and more than 45,200 citations, Dr. Sternberg ranks among the World’s Top 2% Scientists (Stanford University) and the top 5% in the Doximity community for citations. She has delivered more than 835 lectures worldwide, influencing clinical practice, policy, and guidelines in oncology. Her leadership roles in international organizations such as ASCO, ESMO, ECCO, and EORTC demonstrate her far-reaching influence.

Academic Citations

Dr. Sternberg’s research impact is widely recognized. Her publications in high-impact journals such as New England Journal of Medicine, Lancet Oncology, and Journal of Clinical Oncology have shaped global treatment standards. Her works are consistently cited in clinical guidelines, trial protocols, and oncology education, affirming her stature as a thought leader in medical oncology.

Legacy and Future Contributions

Dr. Sternberg’s legacy lies not only in transformative research but also in mentorship. She has nurtured generations of oncologists, fostering innovation and translational research. Currently, she co-leads the Career Development Program in the Bladder SPORE initiative, ensuring the pipeline of future oncology leaders. Her pioneering role in AI in oncology positions her to continue shaping the future of precision medicine, bridging clinical care with technological innovation.

Conclusion

Dr. Cora Sternberg exemplifies the qualities of an Outstanding Scientist—visionary leadership, transformative research, global influence, and unwavering dedication to advancing oncology. Her lifelong contributions to clinical practice, groundbreaking research, academic mentorship, and adoption of emerging technologies ensure her lasting impact on the medical community and future generations of scientists.

Notable Publications

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100" 

  • Author: homas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Cancers
  • Year: 2025

"The Use of Artificial Intelligence for Cancer Therapeutic Decision-Making" 

  • Author: Olivier Elemento; Sean Khozin; Cora N. Sternberg
  • Journal: NEJM AI
  • Year: 2025

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100" 

  • Author: Thomas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Preprint
  • Year: 2025

"Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591" 

  • Author: Scott T. Tagawa; Charlene Thomas; A. Oliver Sartor; Michael Sun; Judith Stangl-Kremser; Mahelia Bissassar; Shankar Vallabhajosula; Sandra Huicochea Castellanos; Jones T. Nauseef; Cora N. Sternberg et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2024

"Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial" 

  • Author: Maha Hussain; Bertrand Tombal; Fred Saad; Karim Fizazi; Cora N. Sternberg; E. David Crawford; Neal Shore; Evgeny Kopyltsov; Arash Rezazadeh Kalebasty; Martin Bögemann et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2023